CTOs on the Move

Saint Peters Healthcare System

www.saintpetershcs.com

 
Saint Peters Healthcare System, Inc. is a New Jersey nonprofit corporation sponsored by the Roman Catholic Diocese of Metuchen. The System consists of Saint Peters University Hospital, Saint Peters Health & Management Services Corporation and The Saint Peters Foundation. Saint Peters Healthcare System was formed in 2007 and reflects the expansive scope of health and wellness services we offer to our community. Our services are offered to all. We are a Catholic institution with a capital C and a small c. We draw inspiration from our religious heritage. Our care for others is universal, extending to those of other faiths and in ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details
Jordan Tannenbaum
Vice President and Chief Information Officer Profile

Jobs

Chief Information Security Officer

Saint Peters Healthcare System New Brunswick, NJ

Similar Companies

FIRST SMILE HOME HEALTH CARE

First Smile Home Health Care is a company that provides home health services in Sunland, California, including nursing, therapy, medical equipment, home health aide, and medical social worker services.

Burke Williams

Burke Williams is a Culver City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Oral Surgery Partners

Oral Surgery Partners is a practice management company that provides professional management services for leading oral diagnostic and surgical practices for any issues that affect the mouth, teeth, and facial region.

Adam Nutrition

Adam Nutrition is a Mira Loma, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Acucela

Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.